20245 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
#1502Medicine for prevention or treatment of diabetes
#1503Pharmaceutical solution formulations containing 17-AAG
#1504Activators of peroxisome proliferator-activated receptor
#1505Topical regulation of triglyceride metabolism
#1506Method of cancer treatment
#1507Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
#1508Compositions comprising one or more policosanols and/or policosanoic acids combined with sterol and/or steroid based ascorbic acid derivatives, and uses thereof
#1509Anti-cancer nitro- and thia-fatty acids
#1510Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils
#1511Sequential ordered fatty acid alpha oxidation and delta9 desaturation are major determinants of lipid storage and utilization in adipocytes
#1512Potentiation of therapeutic effects of fatty acids
#1513Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity
#1514Polypeptoid pulmonary surfactants
#1515Esterified fatty acid composition
#1516Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
#1517Compositions and methods for body weight management
#1518Regulation of phospholipase D activity
#1519Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
#1520Novel cochleate formulations
#1521Anti-inflammatory nitro- and thia- fatty acids
#1522Anti-inflammatory nitro- and thia-fatty acids
#1523Anti-inflammatory nitro-and thia-fatty acids
#1524Antiinfective free intramammary veterinary composition
#1525Treatment of cancer by administration of perfluorooctanoic acid
#1526Biocidal agents and veterinary methods
#1527Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
#1528Compositions and dosage forms for enhanced absorption
#1529Administration of levodopa and carbidopa
#1530Compositions and dosage forms for enhanced absorption of iron
#1531Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin
#1532Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
#1533Methods and compositions for the attenuation and/or prevention of stress/catabolic responses
#1534Compositions and dosage forms for enhanced absorption of metformin
#1535Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent
#1536Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease
#1537Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
#1538Co-beadlet of dha and rosemary and methods of use
#1539Pharmaceutical and nutritional compositions
#1540Cosmetic composition and method for retarding hair growth
#1541Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
#1542Method of inhibiting angiogenesis
#1543Method for treating glaucoma comprising administering α-lipoic acid
#1544Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance
#1545Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
#1546Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids
#1547Methods of modulating angiogenesis and cancer cell proliferation
#1548Methods and materials for treating and preventing inflammation of mucosal tissue
#1549Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
#1550Compound for treatment of external secretion disorders
#1551Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#1552Transdermal and topical administration of drugs using basic permeation enhancers
#1553Methods of attenuating autoimmune disease and compositions useful therefor
#1554Pharmaceutically active uridine esters
#1555Methods and formulations for counteracting infection of mucosa or skin
#1556Pharmaceutically active uridine esters
#1557Hydroxyl compounds and compositions for cholesterol management and related uses
#1558Pharmaceutically active uridine esters
#1559Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease
#1560Composition for treatment of tinea pedis and method of use
#1561Compositions, kits, and methods for treating gastrointestinal conditions
#1562Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
#1563Pharmaceutical compositions of short-acting sedative hypnotic agent
#1564Substances for breaking down conformation of microbes
#1565Strontium compound for treatment of sub-dermal soft tissue pain
#1566Prophylactic agent of hypertension containing a conjugated fatty acid as an effective ingredient and the use thereof
#1567Nutritional composition for controlling blood sugar level
#1568Composition for improving respiratory health of companion animals
#1569Compositions and methods for treating endocrine diseases and disorders
#1570Compositions and methods for diagnosis and treatment of neuromuscular disorders
#1571Composition and method of using the same
#1572Treatment method for primary premature ejaculation
#1573Milkweed seed oil administered to animals